Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
Fl 6
San Francisco, CA 94143Phone+1 415-885-3882
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2012 - 2015
David Geffen School of Medicine at UCLAClass of 2012
Certifications & Licensure
CA State Medical License 2013 - 2026
MA State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer Start of enrollment: 2019 Jun 06
Roles: Contact, Principal Investigator
- Plasma-Adapted First-Line Pembro In NSCLC Start of enrollment: 2020 Jan 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 577 citationsThe Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross
Cancer Cell. 2018-09-10 - 27 citationsTumor fraction-guided cell-free DNA profiling in metastatic solid tumor patientsDana W.Y. Tsui, Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens
Genome Medicine. 2021-05-31 - 423 citationsAnalysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L. Cheng, Joshua Armenia, Sumit Middha, Karen A. Autio
JAMA Oncology. 2019-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
